Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 05, 2026 19:32 ET | Source: Kailera Therapeutics, Inc.

Hengrui Pharma and Kailera Therapeutics Present Ribupatide Clinical Data at ADA 2026

Hengrui Pharma and Kailera Therapeutics Present Ribupatide Clinical Data at ADA 2026
June 05, 2026 16:45 ET | Source: Zealand Pharma

New data from Phase 2 ZUPREME-1 trial at the American Diabetes Association 2026 Scientific Sessions further support potential of petrelintide to redefine the weight management experience for people living with overweight and obesity

Press release – No. 13 / 2026 New data from Phase 2 ZUPREME-1 trial at the American Diabetes Association 2026 Scientific Sessions further support potential of petrelintide to redefine the weight...
June 05, 2026 16:05 ET | Source: Structure Therapeutics Inc.

Structure Therapeutics Announces Publication in Nature Medicine Highlighting Phase 2b ACCESS Program of Aleniglipron for Obesity

Publication presented concurrently with oral presentation at American Diabetes Association’s 86th Scientific Sessions from ACCESS development program with aleniglipron, a once-daily oral small...
June 05, 2026 15:45 ET | Source: Rivus Pharmaceuticals, Inc.

Rivus Pharmaceuticals Announces Preclinical Data for RV-8451, a Muscle-Preserving, Oral GLP-1, at ADA 2026 Scientific Sessions

Preclinical Data for RV-8451, a Muscle-Preserving, Oral GLP-1, Featured in Oral Presentation Today at ADA 2026 Scientific Sessions
June 04, 2026 07:00 ET | Source: Regeneron Pharmaceuticals, Inc.

Regeneron to Highlight Progress Across Its Metabolic Disease, Ophthalmology and Rare Disease Pipelines at ADA and ENDO

TARRYTOWN, N.Y., June 04, 2026 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that new clinical data and research from its metabolic disease, ophthalmology and...
June 03, 2026 02:00 ET | Source: Novo Nordisk A/S

Wegovy® pill launches in the UAE as Novo Nordisk expands global access to obesity care

Novo Nordisk is launching Wegovy® pill in the UAE, the first country outside the US, to make the Wegovy® pill available to people living with obesity
June 02, 2026 09:15 ET | Source: KnowFully Learning Group

EfficientCME Wins Top Poster Award at the Obesity Medicine Association's 2026 Annual Conference

EfficientCME has been named a Top Poster/Abstract at the Obesity Medicine Association's (OMA) 2026 Annual Conference.
May 28, 2026 16:05 ET | Source: Kailera Therapeutics, Inc.

Kailera Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference

Kailera will present at the 2026 Jefferies Global Healthcare Conference on Thursday, June 4, at 10:30 am EDT.
May 27, 2026 10:40 ET | Source: Spherix Global Insights

Eli Lilly’s Oral GLP-1 Foundayo Trails Novo Nordisk’s Wegovy Pill in Early Obesity Launch Uptake, According to Spherix Global Insights

Exton, PA, May 27, 2026 (GLOBE NEWSWIRE) -- As the obesity treatment landscape rapidly evolves, newly launched oral GLP-1 based treatments are introducing alternate treatment options for patients...
May 27, 2026 03:00 ET | Source: Zealand Pharma

Zealand Pharma to Present Data at the American Diabetes Association's 2026 Scientific Sessions

Press release – No. 10 / 2026 Zealand Pharma to Present Data atthe American Diabetes Association's 2026 Scientific Sessions Late-breaking Phase 2 ZUPREME-1 data on petrelintide to be featured as...